Analyst Upgrades

• Netflix (NFLX) and Zions Bancorp (ZION) to outperform from neutral at Credit Suisse.
• Akamai (AKAM) to buy from neutral at Merriman.
• CSX (CSX) to overweight from equal weight at Barclays.
• Nordstrom (JWN) to buy from neutral, WellCare (WCG) to conviction buy from buy and Humana (HUM) to neutral from sell at Goldman.
• E-Commerce China Dangdang (DANG) to overweight from neutral at Piper Jaffray.
• VMware (VMW) to buy from neutral at BofA/Merrill.
• Celanese (CE) to overweight from equal weight at Morgan Stanley.

Analyst Upgrades

• Siemens (SI) to buy from hold at Deutsche Bank.
• Diamond Offshore (DO) to market perform from underperform at FBR Capital.
• MeadWestvaco (MWV) to conviction buy from neutral at Goldman.
• TD AmeriTrade (AMTD) and Cabot Oil & Gas (COG) to buy from neutral at BofA/Merrill.
• Janus Capital (JNS) to hold from sell at Citigroup.
• Motorola Mobility (MMI) to buy from neutral at UBS.
• Frontier Communications (FTR) to neutral from underperform at Macquarie.
• Humana (HUM) to buy from hold at Argus.

Analyst Upgrades

• Medicis (MRX) to overweight from neutral at Piper Jaffray, to outperform from market perform at Bernstein, to outperform from sector perform at RBC Capital and to overweight from neutral at JPMorgan.
• Wellpoint (WLP) to buy from neutral at Davenport.
• Humana (HUM) to buy from hold at Jefferies.
• Frontier Oil (FTO) to equal weight from underweight and Resources Connection (RECN) to overweight from equal weight at Barclays.

Analyst Upgrades

• Molycorp (MCP) to overweight from neutral at JPMorgan.
• Humana (HUM), HealthSpring (HS) and UnitedHealth (UNH) to buy from neutral at UBS.
• Williams Cos. (WMB) to conviction buy from neutral and UBS (UBS) to buy from neutral at Goldman.
• China Kanghui (KH) to overweight from neutral at Piper Jaffray.
• Arthur J. Gallagher (AJG) to buy from hold at Citigroup.
• Armstrong World (AWI) to buy from hold at BB&T.
• Time Warner (TWX) to buy from hold at Benchmark Co.
• Calpine (CPN) to overweight from equal weight at Barclays.
• 3M Company (MMM) to neutral from underperform and Kirby (KEX) to buy from underperform at BofA/Merrill.

Analyst Upgrades

• Polo Ralph Lauren (RL) to neutral from underperform at BofA/Merrill.
• Sigma-Aldrich (SIAL) to outperform from market perform at Leerink.
• Petrobras (PBR) to overweight from equal weight at Barclays.
• Silvercorp Metals (SVM) to buy from neutral at UBS.
• PROS (PRO) to buy from hold at Jefferies.
• Power Integrations (POWI) and Monolithic Power (MPWR) to buy from neutral at Roth Capital.
• Diodes (DIOD) to outperform from neutral at RW Baird.
• Whole Foods (WFMI) to hold from sell at Hapoalim.
• Sinclair Broadcast (SBGI) to overweight from neutral at JPMorgan.
• Sappi (SPP) to outperform from neutral at Macquarie.
• Alpha Natural (ANR) to buy from hold at BB&T.
• Watts Water (WTS) to buy from hold at Brean Murray.

Humana (HUM), one of the nations' biggest providers of private run Medicare Advantage health plans, showed mixed results on Monday in their Q4 results. Revenues were higher, but net earnings fell, due mainly to the acquisition of Concentra Inc. Concentra provides services such as occupational medicine , urgent care and physical therapy.

The company reported a profit of $107.3 million or 63 cents a share, down from $250.7 million of $1.48 a share a year ago, as reported in the Wall Street Journal. The latest period included $1.02 a share in acquisition and related costs. Revenue increased 9.4% to $8.35 billion. Analysts had predicted earnings of 81 cents on revenue of $8.36 billion.

No more Government Motors. Now it's just General Motors, like back in the good old days. The GM IPO raised $20.1 billion from investors today, and the stock has maintained a price throughout the day right around $2/share higher than the $33/share IPO price. Counteracting the bullish news from GM, the US Labor Department said that initial unemployment claims rose by 2,000 last week, to a seasonally adjusted 439,000. Not real good news, but this is near the lowest unemployment level in two years and the average has fallen by about 4.2% over the past five weeks.

The news from Ireland, where the government has been moving toward agreeing to a loan to bail out the country's faltering banks, has boosted the euro, but the gains have been small because traders worry about Portugal, Spain, and Italy needing a similar dose of lending. Yields on 10-year US Treasuries rose to 2.92% on signs of improvement in the US economy and a concomitant rise in risk appetite among investors.

Dow Jones 11,181.23 +173.35 (1.57%)
S&P 500 1,196.68 +18.09 (1.53%)
Nasdaq 2,514.40 +38.39 (1.55%)

Today started out strong and ended up even stronger with triple-digit DJIA gains. The reports from ISM showed no manufacturing recession and actually showed more employment improvements. This was on the heels of a strong Chinese auto figure and on all major indexes outside of the US trading higher. The S&P 500 even got back above its 200-day moving average.

Here were today's unofficial closing bell readings:

Dow Jones 10,674.38 +208.44 (1.99%)
S&P 500 1,125.86 +24.26 (2.20%)
Nasdaq 2,295.36 +40.66 (1.80%)

Humana Inc. (HUM), whose colleagues include Aetna Inc. (AET) and CIGNA Corporation (CI), reported Q1 earnings earlier today. The health insurer isn't doing so well, unfortunately. In late trading, shares were down almost 3% to $43.73. Volume is above the norm, as you might expect.

I've covered many stocks that are near their 52-week highs, but this one doesn't fall into such a desirable category. Alas, the 52-week high on the shares stands at $52.66. And, as you can see from the following one-year chart, the stock began its pullback after it topped out in January. Since then, things haven't been too exciting.

Humana Inc. (HUM), who's shares (like other insurers') received a nice bump from the outcome of the special election in Massachusetts, is scheduled to discuss its fourth-quarter 2009 financial results and 2010 guidance in a conference call Monday, Feb. 1, at 9:00 AM (ET). A live webcast of the call will be available at the company's website.

During the three months that ended in December, Humana expanded its Medicare offerings and launched a share buyback program and a social media tool. Analysts surveyed by Thomson Reuters are looking for earnings for that period to have grown 27.7% year over year to $1.48 cents per share. Revenue for the quarter is expected to be 4.0% higher to $7.8 billion.

Analyst Upgrades

• Credit Suisse views Bank of America (BAC) as the "cheapest" large-cap bank and said the recent TARP repayment removes a significant overhang. The firm upgraded shares to outperform from neutral and raised its target to $21 from $17.
• Piper Jaffray upgraded Bed Bath & Beyond (BBBY) to neutral from underweight following the company's better-than-expected Q3 results. The firm has a $43 price target on the stock.
• Caris upgraded Zumiez (ZUMZ) to above average from average following the company's better-than-expected December sales report. The firm raised its target on shares to $17 from $14.
• Humana (HUM) was upgraded to equal weight from underweight at Barclays.
• Zimmer (ZMH) was upgraded to buy from neutral at BofA/Merrill.
• Applied Industrial (AIT) was upgraded to buy from hold at KeyBanc.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Activision Blizzard Inc. (NASDAQ: ATVI) said its Q3 profit declined despite the popularity of Guitar Hero.
• Blackboard Inc. (NASDAQ: BBBB) said Q3 revenue surged and its offered impressive cash flow numbers.
• Boston Beer Co. Inc. (NYSE: SAM) easily beat Q3 earnings estimates and raised its full-year guidance.
• Cisco Systems Inc. (NASDAQ: CSCO) lower Q1 results topped estimates and sent shares higher.
• Cognizant Technology Solutions Inc. (NASDAQ: CTSH) was upgraded following its strong Q3 results.
• Corporate Executive Board (NASDAQ: EXBD) received an analyst's upgrade following the Q3 results.

While the debate over health care reform rages on, hospital operator Tenet Healthcare Corp. (NYSE: THC) said Tuesday it swung to a loss in the third quarter, one day after health insurer Humana Inc. (NYSE: HUM) posted a 65% jump in its third-quarter profit.

Tenet said it lost $3 million, or a penny per share. That compares with a profit of $104 million, or 22 cents per share, a year earlier. But, Tenet reported a one-time gain of $140 million a year ago after selling investments.

It's official: the holiday season is here, marking the beginning of the race to the end of the year. It's also time for another FOMC interest rate decision, as well as for another look at the employment situation, perhaps the most dreaded measure of the economic recovery in the U.S. This week will bring the Challenger job cut announcements for October on Wednesday, initial jobless claims for last week and the Monster Employment Index for October on Thursday, and the employment numbers for October on Friday.

The earnings season rolls on this week as well, and analysts surveyed by Thomson Reuters are expecting good showings from the reports of Boston Beer Company Inc. (NYSE: SAM), DirecTV Group Inc. (NASDAQ: DTV), Sara Lee Corp. (NYSE: SLE), Starbucks Corp. (NASDAQ: SBUX), and Whole Foods Market Inc. (NASDAQ: WFMI).

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Activision Blizzard Inc. (NASDAQ: ATVI) reported better-than-expected Q2 results, sending shares higher.
• Blackstone Group (NYSE: BX) said it swung to a Q2 profit despite a dearth of leveraged buyouts.
• CBS Corp. (NYSE: CBS) Q2 earnings declined but still topped estimates, sending shares higher.
• Coinstar Inc. (NASDAQ: CSTR) reported stellar Q2 results driven by its the popularity of RedBox.
• Clorox Co. (NYSE: CLX) posted solid Q4 earnings but said revenues were flat due to currency effects.
• Duke Energy Corp. (NYSE: DUK) lower Q2 earnings beat expectations by a penny but revenue fell short.